paradigm changes in the perioperative setting for non-small cell lung cancer - karen reckamp, md
Published 4 months ago • 220 plays • Length 22:53Download video MP4
Download video MP3
Similar videos
-
4:28
changing the treatment paradigm for alk-rearranged nsclc
-
53:19
improving survival and cure rates in resectable nsclc with perioperative immunotherapy
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
2:10
how the treatment paradigm for egfr lung cancer will transform
-
58:18
the paradigm of lung cancer from therapy selection to resistance monitoring
-
![reconfiguration - prognosis [2019] full album](https://i.ytimg.com/vi/CRpxCqBd_Zg/mqdefault.jpg)
29:51
reconfiguration - prognosis [2019] full album
-
40:53
alk and ros1 in lung cancer next generation targeted therapies
-
1:05:22
pathology and molecular aspect of lung cancer in the era of ngs dr aparna dhar
-
0:58
what is precision oncology, and why do you need it?
-
1:29
dr. rule on the treatment paradigm in mcl
-
4:56
perioperative management of lung cancer surgeries
-
3:50
take-home messages on the nsclc treatment paradigm
-
1:20
changing treatment paradigms in gynecologic oncology
-
1:05
how will the paradigm trial change the mcrc treatment landscape?
-
55:49
meet the expert: webinar on new paradigm in management of mcrc
-
18:12
perioperative medical management: beyond the or
-
1:11
dr. reckamp on targeted therapy options for rare mutations in nsclc
-
5:28
the ever-evolving treatment paradigm for nsclc
-
29:59
therapeutic guideposts in maintenance therapy: switch vs. continue vs. observe?
-
9:16
changing treatment paradigm for braf-mutant nsclc
-
7:31
rapidly evolving paradigms for treating advanced rcc
-
27:47
understanding the concept of precision oncology in patient-friendly language